Friday, 13 November 2026 Updated 3 hr ago 715 stories Sources RSS

The Wire

The financial desks we read, gathered in one place. Stories we are licensed to carry are reproduced in full with the writer credited; everything else is a headline and a short quotation that links straight to the publisher.

Venture — 715 stories

Tech.eu Venture Full text

Spacetech: Europe’s 10 most-funded companies in H1 2026

European spacetech companies attracted €2.8 billion in H1 2026, with funding concentrated in satellite infrastructure, space intelligence and launch services. France and Finland led investment, while debt financing played a significant…

Spacetech: Europe’s 10 most-funded companies in H1 2026

TechCrunch Venture Full text

Open source AI is booming. Hugging Face explains who profits.

Watch as Hugging Face's Irene Solaiman joins Equity to explain what startups need to know when building on open AI models, and how to evaluate the tools around them and keep the open ecosystem secure.

Open source AI is booming. Hugging Face explains who profits.

Tech.eu Venture Full text

Ukrainian defencetech UFORCE raises $700M Series A at $6B valuation

Co-led by Valor Equity Partners and the UK National Wealth Fund, the funding will scale production of UFORCE's combat-tested autonomous systems across air, land and sea, expanding manufacturing beyond Ukraine.

Ukrainian defencetech UFORCE raises $700M Series A at $6B valuation

TechCrunch Venture Full text

Guidewire buys Hyperexponential for $1.7B in cash

The deal, expected to close sometime next year, is to help bring AI agents to work alongside humans to underwrite, analyze, and price decisions.

Guidewire buys Hyperexponential for $1.7B in cash

EU-Startups Venture Full text

What investors really want to know about IP

European startups raised €21.45 billion ($24 billion) in the second quarter of this year, the region’s strongest quarter for venture funding in four

What investors really want to know about IP

Tech.eu Venture Full text

Biomatter lands $18M to speed up enzyme development with AI

Biomatter develops a computational platform for designing custom enzymes tailored to specific chemical reactions, helping companies in pharmaceuticals, diagnostics, agriculture and industrial biotechnology accelerate enzyme development.

Biomatter lands $18M to speed up enzyme development with AI
More stories

Stories marked Full text are reproduced here under the terms their publisher allows, with the writer credited and the original linked. Everything else is a headline and a short quotation that links straight to the publisher. How we quote · Our sources